Skip to Content

Gemfibrozil

In the US, Gemfibrozil (gemfibrozil systemic) is a member of the drug class fibric acid derivatives and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IV - Elevated VLDL and Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AB04

CAS registry number (Chemical Abstracts Service)

0025812-30-0

Chemical Formula

C15-H22-O3

Molecular Weight

250

Therapeutic Category

Lipid lowering: Fibrate

Chemical Name

Pentanoic acid, 5-(2,5-dimetylphenoxy)-2,2-dimetyl-

Foreign Names

  • Gemfibrozilum (Latin)
  • Gemfibrozil (German)
  • Gemfibrozil (French)
  • Gemfibrozilo (Spanish)

Generic Names

  • Gemfibrozil (OS: BAN, USAN, DCIT, DCF, JAN)
  • CI 719 (IS: Parke-Davis)
  • GEM (IS)
  • Gemfibrozil (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Gemfibrozilum (PH: Ph. Eur. 8)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide